Pfizer Maintains Plaintiffs Failed to Plead Causation, Seeks Dismissal

SAN FRANCISCO - "Supplemental authorities" recently submitted by purchase claims plaintiffs in the federal Bextra/Celebrex MDL do not change the fact that the plaintiffs have failed to plead causation, Pfizer Inc. has asserted in support of its motions to dismiss plaintiffs' second amended master complaints. In Re: Bextra and Celebrex Marketing, Sales Practices and Products Liability Litigation, MDL No. 1699 (N.D. Calif.).

In a June 10 letter brief to Judge Charles R. Breyer of the U.S. District Court for the Northern District of California, Pfizer maintains that the complaints should be dismissed because, inter alia, no named plaintiff claims he …